AEON Biopharma, Inc.

AEON · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$42-$385-$53-$56
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$5$1
Stock-Based Comp.$6$0$6$5
Change in WC$1-$3$6$1
Other Non-Cash-$69$339-$0$19
Operating Cash Flow-$20-$48-$36-$28
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$15$14$41$15
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$1
Financing Cash Flow$15$14$41$14
Forex Effect$0$29$0$0
Net Chg. in Cash-$5-$5$5-$15
Supplemental Information
Beg. Cash$5$10$5$20
End Cash$0$5$10$5
Free Cash Flow-$20-$48-$36-$29
AEON Biopharma, Inc. (AEON) Financial Statements & Key Stats | AlphaPilot